Comparative Effectiveness And Medical Cost of Dabigatran Versus Vitamin K Antagonists From Engel 2- A French Nationwide Cohort Of 100,000 Patients With Non-Valvular Atrial Fibrillation
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1193
https://www.valueinhealthjournal.com/article/S1098-3015(17)31527-9/fulltext
Title :
Comparative Effectiveness And Medical Cost of Dabigatran Versus Vitamin K Antagonists From Engel 2- A French Nationwide Cohort Of 100,000 Patients With Non-Valvular Atrial Fibrillation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31527-9&doi=10.1016/j.jval.2017.08.1193
First page :
A608
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1139